GO:1903259 exon-exon junction complex disassembly: mRNA Surveillance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903259 (exon-exon junction complex disassembly) is the biological process by which the exon junction complex (EJC) is disaggregated into its constituent proteins after mRNA processing and export.
• EJC disassembly is not a single event; it occurs in at least two phases: a slow, translation-independent removal during mRNA maturation and a rapid, translation-dependent removal during the pioneer round of translation.
• The peripheral EJC factor PYM1 is a key disassembly factor that limits non-canonical EJC occupancy in a gene-architecture-dependent manner, thereby tuning mRNA expression.
• Stalled ribosomes can retain EJCs and delay disassembly, linking EJC disassembly to translation quality control and mRNA surveillance.
• Dysregulation of EJC disassembly is implicated in cancer, neurodevelopmental disorders, and ribosomopathies, making it a potential therapeutic target.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of EJC disassembly factors in human disease.
Description
The exon-exon junction complex (EJC) is a multi-protein assembly deposited on mRNA during splicing, approximately 20-24 nucleotides upstream of exon-exon junctions. This complex serves as a molecular mark that influences mRNA export, translation, and nonsense-mediated decay (NMD). The process by which the EJC is disassembled, termed exon-exon junction complex disassembly (GO:1903259), is critical for proper mRNA metabolism and gene expression. Understanding this process is essential because persistent or misregulated EJCs can alter translation efficiency and mRNA stability, contributing to disease. Recent studies have revealed that EJC disassembly is a regulated, multi-step process involving both translation-independent and translation-dependent mechanisms. The identification of PYM1 as a key disassembly factor has further highlighted the complexity and gene-specific nature of EJC removal. This article provides a comprehensive overview of GO:1903259, integrating structural, mechanistic, and disease-related insights from authoritative literature.
exon-exon junction complex disassembly At A Glance
| GO ID | GO:1903259 |
|---|---|
| GO term | exon-exon junction complex disassembly |
| Ontology | biological_process |
| Synonym | EJC disassembly |
| Major function | Disaggregation of the exon junction complex into its constituent proteins |
| Related complex | Exon-exon junction complex (EJC) |
| Key factor | PYM1 (Pym1) acts as a disassembly factor |
| Cellular context | Occurs in the cytoplasm and nucleus, associated with mRNA maturation and translation |
What Is GO:1903259?
GO:1903259, exon-exon junction complex disassembly, is defined as the disaggregation of an exon-exon junction complex into its constituent components. In other words, it is the biological process that removes the EJC from mRNA after splicing, allowing the mRNA to proceed through subsequent steps of gene expression. This process is also known as EJC disassembly.
Why Is exon-exon junction complex disassembly Important in Cell Biology?
EJC disassembly is a fundamental step in mRNA metabolism because it determines the lifetime and functional state of the EJC on mRNA. Proper disassembly ensures that mRNA can be efficiently translated and degraded, while defects can lead to aberrant translation, NMD dysregulation, and disease. Moreover, the discovery that PYM1 limits non-canonical EJC occupancy in a gene-architecture-dependent manner underscores the importance of this process in tuning gene expression. Thus, studying GO:1903259 provides insights into basic RNA biology and offers potential therapeutic avenues for diseases linked to mRNA dysregulation.
• EJC disassembly is required for the pioneer round of translation and proper mRNA quality control.
• PYM1-mediated disassembly prevents non-canonical EJC accumulation, which can otherwise alter mRNA expression.
• Defects in EJC disassembly are linked to cancer, as EJC components are often overexpressed in tumors.
• Neurodevelopmental disorders may arise from mutations in EJC disassembly factors, affecting neuronal mRNA metabolism.
• Ribosomopathies, such as Diamond-Blackfan anemia, may involve impaired EJC turnover.
• Understanding EJC disassembly aids in the design of mRNA therapeutics and vaccines.
• EJC disassembly is a potential target for antiviral strategies, as some viruses hijack EJC components.
• Studying EJC disassembly can reveal general principles of mRNP remodeling.
• EJC disassembly factors like PYM1 are emerging as biomarkers for certain cancers.
• CRISPR screens targeting EJC disassembly genes can identify novel therapeutic targets.
What Happens During exon-exon junction complex disassembly?
Translation-independent disassembly
In simple terms: The EJC can be removed slowly even before the mRNA is translated.
A slow, translation-independent disassembly of the EJC occurs during mRNA maturation and export. This process is thought to involve the gradual dissociation of peripheral EJC components, such as PYM1, which binds to the EJC core and promotes its disassembly. This phase is critical for resetting the EJC status of mRNAs before they engage with ribosomes.
Translation-dependent disassembly
In simple terms: When ribosomes translate the mRNA, they physically remove the EJC.
During the pioneer round of translation, the ribosome encounters the EJC and displaces it from the mRNA. This translation-dependent disassembly is rapid and ensures that the EJC does not interfere with subsequent rounds of translation. Stalled ribosomes can delay this process, leading to EJC retention and altered mRNA surveillance.
Role of PYM1 in EJC disassembly
In simple terms: PYM1 is a protein that helps take apart the EJC.
PYM1 (Pym1) is a peripheral EJC factor that promotes disassembly by interacting with the EJC core. It limits non-canonical EJC occupancy in a gene-architecture-dependent manner, thereby tuning mRNA expression. Knockdown of PYM1 leads to EJC accumulation and changes in mRNA levels, highlighting its essential role in EJC disassembly.
EJC core components and their fate
In simple terms: The EJC is made of several proteins that must be separated.
The EJC core consists of eIF4A3, MAGOH, Y14 (RBM8A), and MLN51 (CASC3). During disassembly, these components are released from the mRNA. Structural studies have provided insights into how these proteins interact and how they are removed. The disassembly process is tightly regulated to prevent premature or delayed release, which could affect mRNA function.
Coupling to mRNA surveillance
In simple terms: EJC disassembly is linked to quality control of mRNA.
EJC disassembly is intimately coupled to nonsense-mediated decay (NMD) and other mRNA surveillance pathways. If an EJC remains on an mRNA downstream of a premature stop codon, it triggers NMD. Thus, proper disassembly is essential to distinguish normal from aberrant mRNAs.
Key Genes Involved in GO:1903259 exon-exon junction complex disassembly
The following genes and proteins are key players in exon-exon junction complex disassembly, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PYM1 | Promotes EJC disassembly; limits non-canonical EJC occupancy | Knockdown leads to EJC accumulation and altered mRNA expression |
| EIF4A3 | Core EJC component; RNA helicase | Mutations linked to Richieri-Costa-Pereira syndrome |
| MAGOH | Core EJC component; involved in EJC stability | Essential for development; knockout is lethal in mice |
| RBM8A | Core EJC component (Y14); binds mRNA | Mutations cause thrombocytopenia-absent radius syndrome |
| CASC3 | Core EJC component (MLN51); enhances EJC assembly | Overexpressed in breast cancer |
| UPF1 | NMD factor; interacts with EJC during surveillance | Key for mRNA quality control; mutations linked to disease |
| UPF2 | NMD factor; binds EJC to trigger NMD | Involved in EJC-dependent NMD |
| UPF3B | NMD factor; interacts with EJC | Mutations associated with intellectual disability |
| SMG1 | Kinase in NMD; phosphorylates UPF1 | Regulates EJC-dependent NMD |
| SMG5 | NMD factor; promotes mRNA decay | Part of EJC disassembly-coupled decay |
| SMG6 | Endonuclease in NMD; cleaves mRNA | Links EJC disassembly to mRNA degradation |
| SMG7 | NMD factor; recruits decay machinery | Involved in EJC-mediated mRNA turnover |
| RNPS1 | EJC-associated factor; modulates splicing and NMD | Regulates EJC function |
| SRSF1 | Splicing factor; influences EJC deposition | Overexpressed in cancers |
| DDX39B | Export factor; interacts with EJC | Links EJC to mRNA export |
| NXF1 | Export receptor; binds EJC-associated mRNPs | Required for mRNA export |
| ALYREF | Export adaptor; couples EJC to export | Part of TREX complex |
How Is exon-exon junction complex disassembly Regulated?
EJC disassembly is regulated at multiple levels. Translation-dependent disassembly is coupled to ribosome progression, and stalled ribosomes can delay EJC removal. PYM1 availability and post-translational modifications may influence disassembly efficiency. Additionally, gene architecture, such as intron length and exon junction position, affects PYM1-mediated disassembly. The process is also integrated with NMD, where UPF proteins and SMG factors modulate the fate of EJCs.
exon-exon junction complex disassembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PYM1 | Cancer, mRNA expression dysregulation | Knockout and overexpression cell lines |
| EIF4A3 | Richieri-Costa-Pereira syndrome | Patient-derived iPSCs with point mutations |
| RBM8A | Thrombocytopenia-absent radius syndrome | Knock-in mouse models |
| UPF1 | Neurodevelopmental disorders | CRISPR knockout neurons |
| CASC3 | Breast cancer | Xenograft models with overexpression |
Cancer
EJC components are frequently overexpressed in various cancers, and dysregulated EJC disassembly can lead to altered mRNA expression profiles that promote tumorigenesis. For example, PYM1 downregulation has been observed in some cancers, leading to EJC accumulation and changes in oncogene expression.
Neurodevelopmental disorders
Mutations in EJC core components such as RBM8A cause thrombocytopenia-absent radius syndrome, which includes neurological defects. Impaired EJC disassembly may contribute to neuronal mRNA dysregulation underlying intellectual disability.
Ribosomopathies
Disrupted EJC disassembly can affect ribosome biogenesis and function, contributing to ribosomopathies like Diamond-Blackfan anemia. The interplay between EJC turnover and translation is critical for erythroid development.
From exon-exon junction complex disassembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PYM1 loss affect global mRNA expression? | PYM1 knockout cell lines (e.g., HeLa, HEK293) |
| How does a point mutation in EIF4A3 affect EJC disassembly? | Knock-in cell lines with patient mutations |
| Can tagged PYM1 be used to track EJC disassembly in live cells? | Knock-in of fluorescent tags (e.g., GFP) |
| What is the effect of PYM1 overexpression on tumor growth? | Overexpression cell lines and mouse xenografts |
| Which genes are essential for EJC disassembly? | Genome-wide CRISPR knockout library screening |
| How does translation inhibition affect EJC disassembly? | Ribo-seq and polysome profiling in knockout cells |
How to Study the exon-exon junction complex disassembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Studying translation-dependent EJC disassembly |
| RNA-seq | mRNA expression and splicing changes | Assessing PYM1 knockout effects |
| Proteomics | Protein interactions and modifications | Identifying EJC disassembly factors |
| Single-molecule FRET | Real-time disassembly kinetics | Mechanistic studies of EJC removal |
| CRISPR screening | Gene essentiality for EJC disassembly | Identifying novel disassembly regulators |
| CLIP-seq | RNA binding sites of EJC proteins | Mapping EJC occupancy |
| Polysome profiling | mRNA distribution across ribosomes | Detecting stalled ribosomes |
| Immunofluorescence | Subcellular localization of EJC components | Visualizing EJC disassembly |
Ribo-seq and polysome profiling
Ribosome profiling (Ribo-seq) can measure translation efficiency and ribosome stalling at exon junctions, providing insights into translation-dependent EJC disassembly. Polysome profiling can separate mRNAs by ribosome occupancy, revealing defects in EJC removal.
RNA-seq and transcriptomics
RNA sequencing can quantify changes in mRNA expression and splicing upon perturbation of EJC disassembly factors. This is particularly useful to study PYM1-mediated tuning of mRNA expression.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify EJC components and their interactions, as well as post-translational modifications that regulate disassembly. Proximity labeling can capture transient interactions during disassembly.
Imaging and single-molecule assays
Fluorescence microscopy and single-molecule FRET can visualize EJC disassembly in real time, providing kinetic parameters. Live-cell imaging of tagged EJC components allows tracking of disassembly dynamics.
How CRISPR Can Be Used to Study GO:1903259 exon-exon junction complex disassembly
Knockout
CRISPR knockout of PYM1 or EJC core genes can abolish disassembly, leading to EJC accumulation and altered mRNA expression. These models are valuable to study the consequences of impaired disassembly.
Point Mutation
Introducing patient-specific point mutations in EIF4A3 or RBM8A via CRISPR can recapitulate disease phenotypes and reveal how specific residues affect EJC disassembly.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous EJC genes allows tracking of disassembly in live cells and purification of complexes for biochemical assays.
Overexpression
Overexpression of PYM1 or other disassembly factors can enhance EJC removal and may suppress tumor growth, providing a basis for therapeutic strategies.
How EDITGENE Supports exon-exon junction complex disassembly Research
Researchers studying exon-exon junction complex disassembly-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for exon-exon junction complex disassembly research.
Frequently Asked Questions About exon-exon junction complex disassembly
What is exon-exon junction complex disassembly?
It is the biological process (GO:1903259) by which the exon junction complex (EJC) is broken down into its individual protein components after mRNA splicing.
What genes are involved in exon-exon junction complex disassembly?
Key genes include PYM1, EIF4A3, MAGOH, RBM8A, CASC3, and NMD factors like UPF1, UPF2, and UPF3B.
Why is EJC disassembly important?
It ensures proper mRNA translation and quality control; defects can lead to cancer, neurodevelopmental disorders, and ribosomopathies.
How is the exon junction complex disassembled?
Disassembly occurs via translation-independent and translation-dependent mechanisms, with PYM1 playing a key role in promoting EJC removal.
What is the role of PYM1 in EJC disassembly?
PYM1 is a peripheral EJC factor that promotes disassembly and limits non-canonical EJC occupancy, thereby tuning mRNA expression.
What diseases are associated with defective EJC disassembly?
Cancer, thrombocytopenia-absent radius syndrome, Richieri-Costa-Pereira syndrome, and some ribosomopathies.
How can I study EJC disassembly in the lab?
Use CRISPR knockout/knock-in models, Ribo-seq, RNA-seq, proteomics, and imaging techniques.
What are the methods to measure EJC disassembly?
Ribo-seq, polysome profiling, single-molecule FRET, and CLIP-seq are commonly used.
Is EJC disassembly linked to nonsense-mediated decay?
Yes, EJC disassembly is coupled to NMD; retained EJCs trigger NMD of aberrant mRNAs.
Can CRISPR be used to study EJC disassembly?
Absolutely; CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting EJC disassembly.
Conclusion
Exon-exon junction complex disassembly (GO:1903259) is a critical biological process that ensures proper mRNA metabolism and gene expression. Recent advances have highlighted the role of PYM1 and the interplay between translation and EJC removal. Dysregulation of this process is linked to various human diseases, making it an attractive target for therapeutic intervention. Continued research using CRISPR-based models and advanced sequencing technologies will further unravel the mechanistic details and disease relevance of EJC disassembly.
References
- 1. Bensaude O et al.. 2024. Exon-junction complex association with stalled ribosomes and slow translation-independent disassembly.. Nat Commun 15(1):4209 PMID: 38760352
- 2. Sanjeev M et al.. 2025. PYM1 limits non-canonical Exon Junction Complex occupancy in a gene architecture dependent manner to tune mRNA expression.. Nat Commun 16(1):8138 PMID: 40885765
- 3. Gerbracht JV et al.. 2018. The exon junction complex: structural insights into a faithful companion of mammalian mRNPs.. Biochem Soc Trans 46(1):153-161 PMID: 29351963
- 4. Sanjeev M et al.. 2025. PYM1 limits non-canonical Exon Junction Complex occupancy in a gene architecture dependent manner to tune mRNA expression.. bioRxiv PMID: 40161626
